The renin‐angiotensin‐aldosterone system and its suppression

MK Ames, CE Atkins, B Pitt - Journal of veterinary internal …, 2019 - Wiley Online Library
Chronic activation of the renin‐angiotensin‐aldosterone system (RAAS) promotes and
perpetuates the syndromes of congestive heart failure, systemic hypertension, and chronic …

Canine degenerative myxomatous mitral valve disease: natural history, clinical presentation and therapy

M Borgarelli, J Haggstrom - Veterinary Clinics: Small Animal …, 2010 - vetsmall.theclinics.com
Chronic degenerative mitral valve disease as a result of myxomatous degeneration (MMVD)
is the most common acquired cardiovascular disease in the dog representing 75% of all …

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs

BW Keene, CE Atkins, JD Bonagura… - Journal of veterinary …, 2019 - Wiley Online Library
This report, issued by the ACVIM Specialty of Cardiology consensus panel, revises
guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also …

Cardiovascular–renal axis disorders in the domestic dog and cat: a veterinary consensus statement

JL Pouchelon, CE Atkins, C Bussadori… - Journal of small …, 2015 - Wiley Online Library
OBJECTIVES There is a growing understanding of the complexity of interplay between renal
and cardiovascular systems in both health and disease. The medical profession has …

Эндокардиоз атриовентрикулярных клапанов сердца у собак

АА Руденко, ЮА Ватников, ПА Руденко… - 2022 - elibrary.ru
В монографии на основе новейших прикладных и фундаментальных достижений
ветеринарной медицины рассматривается наиболее распространенная патология …

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril …

M Coffman, E Guillot, T Blondel… - Journal of veterinary …, 2021 - Wiley Online Library
Background The renin‐angiotensin‐aldosterone system (RAAS), when chronically activated,
is harmful and RAAS‐suppressive drugs are beneficial in the treatment of congestive heart …

Mineralocorticoid receptor in cardiovascular diseases—Clinical trials and mechanistic insights

J Bauersachs, N López‐Andrés - British Journal of …, 2022 - Wiley Online Library
Aldosterone binds to the mineralocorticoid receptor (NR3C2), a transcription factor of the
nuclear receptor family, present in the kidney and in various other non‐epithelial cells …

Short‐term efficacy and safety of torasemide and furosemide in 366 dogs with degenerative mitral valve disease: the TEST study

V Chetboul, JL Pouchelon, J Menard… - Journal of veterinary …, 2017 - Wiley Online Library
Background Furosemide is the only loop diuretic recommended by the ACVIM consensus
guidelines for treatment of congestive heart failure (CHF) in dogs related to degenerative …

Pharmacologic management of myxomatous mitral valve disease in dogs

CE Atkins, J Häggström - Journal of Veterinary Cardiology, 2012 - Elsevier
Myxomatous mitral valve disease (MMVD) causing mitral regurgitation is the most important
disease of the heart in small animal cardiovascular medicine. Because MMVD is an …

Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease

GD Peddle, GE Singletary, CA Reynolds… - Journal of Veterinary …, 2012 - Elsevier
OBJECTIVES: Diuretic therapy reduces preload and relieves congestion secondary to
cardiac dysfunction. Torsemide (torasemide) is a loop diuretic with longer duration of action …